Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series

Lerzan Dogan; Dilaver Kaya; Tugce Sarikaya; Rehile Zengin; Alp Dincer; Ibrahim Ozkan Akinci; Nazire Afsar

doi:10.1016/j.bbi.2020.05.022

Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series

Brain Behav Immun. 2020 Jul:87:155-158. doi: 10.1016/j.bbi.2020.05.022. Epub 2020 May 7.

Authors

Lerzan Dogan¹, Dilaver Kaya², Tugce Sarikaya¹, Rehile Zengin³, Alp Dincer⁴, Ibrahim Ozkan Akinci¹, Nazire Afsar⁵

Affiliations

¹ Department of Anesthesiology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
² Neurology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
³ Infectious Diseases, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
⁴ Radiology, and Center for Neuroradiological Applications and Research, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
⁵ Neurology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey. Electronic address: nazire.afsar@acibadem.com.

Abstract

Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).

Keywords: Autoimmune; COVID-19; Encephalitis; Plasmapheresis.

Publication types

Case Reports

MeSH terms

Autoimmune Diseases / therapy
Betacoronavirus / pathogenicity
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / therapy*
Female
Humans
Male
Meningoencephalitis / complications
Meningoencephalitis / therapy
Middle Aged
Pandemics
Plasmapheresis / methods*
Pneumonia, Viral / complications
Pneumonia, Viral / therapy*
SARS-CoV-2